- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 26 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 1 residues within 4Å:- Chain A: N.615
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 2 residues within 4Å:- Chain B: E.87, N.88
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 3 residues within 4Å:- Chain B: N.183, D.184, N.185
No protein-ligand interaction detected (PLIP)NAG-NAG.9: 5 residues within 4Å:- Chain B: N.231, G.234, P.235, F.274, Q.348
No protein-ligand interaction detected (PLIP)NAG-NAG.10: 3 residues within 4Å:- Chain B: K.228, N.238, E.265
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 3 residues within 4Å:- Chain B: N.292, N.328
- Ligands: NAG-NAG-BMA-MAN.15
No protein-ligand interaction detected (PLIP)NAG-NAG.22: 1 residues within 4Å:- Chain C: N.615
No protein-ligand interaction detected (PLIP)NAG-NAG.28: 1 residues within 4Å:- Chain D: N.185
No protein-ligand interaction detected (PLIP)NAG-NAG.42: 3 residues within 4Å:- Chain A: S.527
- Chain E: E.87, N.88
No protein-ligand interaction detected (PLIP)NAG-NAG.61: 1 residues within 4Å:- Chain F: N.624
No protein-ligand interaction detected (PLIP)- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.5: 3 residues within 4Å:- Chain B: N.130, T.186
- Ligands: NAG.65
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.29: 7 residues within 4Å:- Chain B: I.162
- Chain D: P.180, I.181, D.182, R.189, N.194, T.195
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.36: 4 residues within 4Å:- Chain D: N.292, N.328, T.410
- Ligands: NAG-NAG-BMA.34
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.52: 1 residues within 4Å:- Chain E: N.298
No protein-ligand interaction detected (PLIP)- 7 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.6: 3 residues within 4Å:- Chain B: D.133, N.153, Y.170
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:Y.170
NAG-NAG-BMA-MAN.15: 6 residues within 4Å:- Chain B: N.292, H.326, N.328, T.410, T.412
- Ligands: NAG-NAG.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.18: 4 residues within 4Å:- Chain B: N.382, T.384, R.416
- Ligands: NAG-NAG-BMA.19
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.33: 3 residues within 4Å:- Chain D: N.273, T.275, D.276
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.38: 1 residues within 4Å:- Chain D: N.358
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.50: 2 residues within 4Å:- Chain E: N.273, T.275
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.56: 3 residues within 4Å:- Chain E: M.369, N.382, T.384
No protein-ligand interaction detected (PLIP)- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN.11: 13 residues within 4Å:- Chain B: H.66, S.206, E.208, P.209, R.249, V.251, N.259, R.301, I.436, R.441, C.442, S.444
- Ligands: NAG-NAG-BMA.20
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:E.208, B:E.208
NAG-NAG-BMA-MAN-MAN-MAN.49: 10 residues within 4Å:- Chain E: S.206, E.208, V.251, N.259, F.372, N.373, G.375, R.437, C.442, S.444
No protein-ligand interaction detected (PLIP)- 5 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.16: 9 residues within 4Å:- Chain B: N.335, T.390, N.392, N.394, G.395, T.396, W.397, L.399, T.400
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.397
- Hydrogen bonds: B:T.396, B:T.396, B:T.396
NAG-NAG-BMA-MAN-MAN.25: 3 residues within 4Å:- Chain D: N.130, T.186
- Ligands: NAG-NAG-BMA.27
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.26: 6 residues within 4Å:- Chain D: R.135, N.153, S.155, K.168, Y.170, D.317
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:K.168
NAG-NAG-BMA-MAN-MAN.43: 3 residues within 4Å:- Chain E: N.130, T.132, T.186
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN.53: 5 residues within 4Å:- Chain E: N.292, H.326, N.328, T.410
- Ligands: NAG-NAG-BMA.51
No protein-ligand interaction detected (PLIP)- 1 x NAG- NAG- MAN- BMA: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.37: 7 residues within 4Å:- Chain D: R.331, N.335, N.394, G.395, T.396, W.397, T.400
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:W.397
- Hydrogen bonds: D:T.396, D:T.396
NAG-NAG-BMA-MAN-MAN-MAN-MAN.54: 7 residues within 4Å:- Chain E: N.335, N.339, W.391, N.394, G.395, T.396, T.400
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:T.396
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 11 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.63: 2 residues within 4Å:- Chain A: N.623, N.624
No protein-ligand interaction detected (PLIP)NAG.65: 6 residues within 4Å:- Chain B: N.130, S.155, F.156, N.157, K.168
- Ligands: NAG-NAG-BMA-MAN.5
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:N.130
- Hydrogen bonds: B:N.130, B:N.157
NAG.66: 2 residues within 4Å:- Chain B: N.351, N.352
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:N.351, B:N.352
NAG.67: 2 residues within 4Å:- Chain B: F.393, N.394
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:N.394
NAG.68: 2 residues within 4Å:- Chain B: T.396, N.398
No protein-ligand interaction detected (PLIP)NAG.69: 1 residues within 4Å:- Chain C: N.624
No protein-ligand interaction detected (PLIP)NAG.71: 1 residues within 4Å:- Chain D: N.352
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:N.352
NAG.72: 1 residues within 4Å:- Chain D: N.398
No protein-ligand interaction detected (PLIP)NAG.74: 3 residues within 4Å:- Chain E: N.183, D.184, N.185
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.185
NAG.75: 3 residues within 4Å:- Chain E: G.350, N.351, N.352
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:N.351, E:N.352
NAG.76: 1 residues within 4Å:- Chain E: N.398
1 PLIP interactions:1 interactions with chain E- Hydrogen bonds: E:N.398
- 3 x 83G: 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione(Non-covalent)
83G.64: 14 residues within 4Å:- Chain B: I.109, W.112, D.113, L.116, V.252, S.371, F.378, I.421, N.422, M.423, W.424, K.429, M.431, M.473
8 PLIP interactions:8 interactions with chain B- Hydrophobic interactions: B:W.112, B:L.116, B:V.252, B:F.378, B:W.424
- Hydrogen bonds: B:D.113, B:W.424
- pi-Stacking: B:W.424
83G.70: 15 residues within 4Å:- Chain D: I.109, W.112, D.113, L.116, V.252, S.371, F.372, N.373, F.378, I.421, N.422, M.423, W.424, K.429, M.431
11 PLIP interactions:11 interactions with chain D- Hydrophobic interactions: D:W.112, D:W.112, D:L.116, D:V.252, D:I.421, D:I.421, D:I.421, D:M.431
- Hydrogen bonds: D:D.113, D:W.424
- pi-Stacking: D:W.424
83G.73: 13 residues within 4Å:- Chain E: I.109, W.112, L.116, V.252, S.371, F.378, I.421, N.422, M.423, W.424, K.429, M.431, M.473
9 PLIP interactions:9 interactions with chain E- Hydrophobic interactions: E:W.112, E:L.116, E:V.252, E:F.378, E:F.378, E:I.421, E:W.424
- Hydrogen bonds: E:W.424
- pi-Stacking: E:W.424
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qi, Y. et al., The membrane-proximal external region of human immunodeficiency virus (HIV-1) envelope glycoprotein trimers in A18-lipid nanodiscs. Commun Biol (2025)
- Release Date
- 2025-02-26
- Peptides
- Envelope glycoprotein gp160: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
DD
EE
AF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-hexamer
- Ligands
- 26 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 10 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 4 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 7 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 5 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- MAN- BMA: alpha-D-mannopyranose-(1-3)-[beta-D-mannopyranose-(1-4)]2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- FUC: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 1 x NAG- NAG- BMA- MAN- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-2)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 2 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 11 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x 83G: 1-[(2R)-4-(benzenecarbonyl)-2-methylpiperazin-1-yl]-2-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)ethane-1,2-dione(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Qi, Y. et al., The membrane-proximal external region of human immunodeficiency virus (HIV-1) envelope glycoprotein trimers in A18-lipid nanodiscs. Commun Biol (2025)
- Release Date
- 2025-02-26
- Peptides
- Envelope glycoprotein gp160: ABCDEF
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
CC
DD
EE
AF
F